Clear. 42.8   F New York
AI-Powered News Summarizer
Top Stories

Dolly Parton learned she funded the Moderna Covid-19 vaccine when the rest of us did

November 18, 2020. Summarized by summa-bot.

The legendary performer said she was excited and proud to have contributed to Moderna's Covid-19 vaccine, which early data found to be 94.5% effective.

And, as of this year, coronavirus vaccine sponsor.

The diminutive diva's $1 million donation to Covid-19 research was partly used to fund Moderna's promising Covid-19 vaccine -- something she didn't even know until her name appeared among other sponsors in a preliminary report on the vaccine.

In media appearances on Tuesday, Parton was beaming with pride and excitement at the news.

Parton, who said she'd found out her donation contributed to the vaccine trial on Tuesday morning, told BBC's "The One Show" she felt "very honored and very proud" to be a small piece of what could be an essential treatment for Covid-19.

"I just felt so proud to have been part of that little seed money that will hopefully grow into something great and help to heal this world," she said.

"I'm a very proud girl today to know I had anything at all to do with something that's going to help us through this crazy pandemic. "

Parton first donated to the Vanderbilt University Medical Center's Covid-19 research efforts in early April, when there were around 200,000 cases of Covid-19 in the US.

The Moderna vaccine is thought to be 94. 5% effective against coronavirus, according to early data released by the company.

Vaccinations could begin as soon as late December, top infectious disease expert Dr. Anthony Fauci said, though they'll be made available first to high-risk groups like health care workers, the elderly and people with underlying medical conditions.

In April, Parton encouraged her fans who could afford it to donate to the Vanderbilt Health Covid-19 research fund.

Summarizer is on Google News. Now you can get the latest AI summarized news on your favorite news platform.

Don't like Google News? We have an RSS Feed for you.